CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG

CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG was reported 173 times

CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Anthracycline Topoisomerase Inhibitor [EPC] 4 0.0016
1 Cytomegalovirus pUL97 Kinase Inhibitor [EPC] 3 0.0012
2 Lymphocyte Growth Factor [EPC] 1 0.0008
3 Bispecific CD20-directed CD3 T Cell Engager [EPC] 3 0.0007
4 Echinocandin Antifungal [EPC] 5 0.0006
5 Calcineurin Inhibitor Immunosuppressant [EPC] 58 0.0004
6 Janus Kinase Inhibitor [EPC] 60 0.0004
7 CD22-directed Immunoconjugate [EPC] 1 0.0003
8 Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] 1 0.0003
9 Bile Acid [EPC] 7 0.0003
10 Human alpha-1 Proteinase Inhibitor [EPC] 1 0.0002
11 Provitamin D2 Compound [EPC] 6 0.0002
12 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 23 0.0002
13 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 23 0.0002
14 Alkylating Drug [EPC] 47 0.0002
15 Antimalarial [EPC] 2 0.0002
16 Antiprotozoal [EPC] 2 0.0002
17 Antimetabolite Immunosuppressant [EPC] 3 0.0001
18 Kinase Inhibitor [EPC] 77 0.0001
19 Azole Antifungal [EPC] 20 0.0001
20 BCL-2 Inhibitor [EPC] 7 0.0001
21 Lipid-based Polyene Antifungal [EPC] 1 0.0001
22 Folate Analog Metabolic Inhibitor [EPC] 34 0.0001
23 Asparagine-specific Enzyme [EPC] 1 0.0001
24 CD20-directed Cytolytic Antibody [EPC] 23 0.0001
25 Selective T Cell Costimulation Modulator [EPC] 10 0.0001
26 Topoisomerase Inhibitor [EPC] 5 0.0001
27 Corticosteroid [EPC] 77 0.0001
28 Nucleoside Metabolic Inhibitor [EPC] 15 0.0001
29 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
30 Carbonic Anhydrase Inhibitor [EPC] 1 0.0000
31 Human Immunoglobulin G [EPC] 1 0.0000
32 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
33 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 4 0.0000
34 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
35 Fluoroquinolone Antibacterial [EPC] 5 0.0000
36 Androgen [EPC] 1 0.0000
37 Leukotriene Receptor Antagonist [EPC] 1 0.0000
38 Osmotic Laxative [EPC] 9 0.0000
39 Programmed Death Receptor-1 Blocking Antibody [EPC] 3 0.0000
40 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 3 0.0000
41 Polyene Antifungal [EPC] 1 0.0000
42 Pyridone [EPC] 1 0.0000
43 Histamine-2 Receptor Antagonist [EPC] 3 0.0000
44 gamma-Aminobutyric Acid-ergic Agonist [EPC] 2 0.0000
45 Leukocyte Growth Factor [EPC] 3 0.0000
46 Purine Antimetabolite [EPC] 2 0.0000
47 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
48 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
49 Serotonin-3 Receptor Antagonist [EPC] 2 0.0000
50 Interleukin-6 Receptor Antagonist [EPC] 2 0.0000
51 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
52 Nucleoside Analog Antiviral [EPC] 1 0.0000
53 Platinum-based Drug [EPC] 3 0.0000
54 Factor Xa Inhibitor [EPC] 3 0.0000
55 Aminosalicylate [EPC] 1 0.0000
56 Antirheumatic Agent [EPC] 1 0.0000
57 Tumor Necrosis Factor Blocker [EPC] 8 0.0000
58 Opioid Agonist [EPC] 2 0.0000
59 alpha-Adrenergic Blocker [EPC] 1 0.0000
60 Proton Pump Inhibitor [EPC] 4 0.0000
61 Expectorant [EPC] 1 0.0000
62 Thiazide Diuretic [EPC] 1 0.0000
63 Vitamin D [EPC] 1 0.0000
64 beta-Adrenergic Blocker [EPC] 1 0.0000
65 Vitamin B12 [EPC] 1 0.0000
66 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
67 Vitamin C [EPC] 1 0.0000
68 Insulin Analog [EPC] 1 0.0000
69 Atypical Antipsychotic [EPC] 1 0.0000
70 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
71 Thalidomide Analog [EPC] 1 0.0000
72 Benzodiazepine [EPC] 1 0.0000